CLDN2 and colorectal carcinoma: We observed that Claudin-2 levels were significantly elevated in primary tumors from CRC patients that relapsed to the liver within 5 years compared to those patients that did not develop liver metastases within 5 years of diagnosis (Supplementary Fig. 6a, b).